ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1

CUSIP: 00484MAA4

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Debt / NOTE 1.750% 6/1
Market price (% of par)
81.58%
Total 13F principal
$330,321,000
Principal change
-$9,754,000
Total reported market value
$269,628,705
Number of holders
39
Value change
-$11,216,966
Number of buys
19
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 00484MAA4?
CUSIP 00484MAA4 identifies 00484MAA4 - ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 as of Q3 2016

As of 30 Sep 2016, ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 was held by 39 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $330,321,000 in principal (par value) of the bond. The largest 10 bondholders included BAKER BROS. ADVISORS LP, CNH PARTNERS LLC, WOLVERINE ASSET MANAGEMENT LLC, ANGELO GORDON & CO., L.P., Davidson Kempner Capital Management LP, UBS OCONNOR LLC, D. E. Shaw & Co., Inc., CAMDEN ASSET MANAGEMENT L P /CA, CITADEL ADVISORS LLC, and JPMORGAN CHASE & CO. This page lists 39 institutional bondholders reporting positions for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.